1fgh

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1fgh" size="450" color="white" frame="true" align="right" spinBox="true" caption="1fgh, resolution 2.05&Aring;" /> '''COMPLEX WITH 4-HYDRO...)
Line 1: Line 1:
-
[[Image:1fgh.gif|left|200px]]<br /><applet load="1fgh" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1fgh.gif|left|200px]]<br /><applet load="1fgh" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1fgh, resolution 2.05&Aring;" />
caption="1fgh, resolution 2.05&Aring;" />
'''COMPLEX WITH 4-HYDROXY-TRANS-ACONITATE'''<br />
'''COMPLEX WITH 4-HYDROXY-TRANS-ACONITATE'''<br />
==Overview==
==Overview==
-
It has been known for many years that fluoroacetate and fluorocitrate when, metabolized are highly toxic, and that at least one effect of, fluorocitrate is to inactivate aconitase. In this paper we present, evidence supporting the hypothesis that the (-)-erythro diastereomer of, 2-fluorocitrate acts as a mechanism based inhibitor of aconitase by first, being converted to fluoro-cis-aconitate, followed by addition of hydroxide, and with loss of fluoride to form 4-hydroxy-trans-aconitate (HTn), which, binds very tightly, but not covalently, to the enzyme. Formation of HTn by, these reactions is in accord with the working model for the enzyme, mechanism. That HTn is the product of fluorocitrate inhibition is, supported by the crystal structure of the enzyme-inhibitor complex at, 2.05-A resolution, release of fluoride stoichiometric with total enzyme, when (-)-erythro-2-fluorocitrate is added, HPLC analysis of the product, slow displacement of HTn by 10(6)-fold excess of isocitrate, and, previously published Mossbauer experiments. When, (+)-erythro-2-fluorocitrate is added to aconitase, the release of fluoride, is stoichiometric with total substrate added, and HPLC analysis of the, products indicates the formation of oxalosuccinate, and its derivative, alpha-ketoglutarate. This is consistent with the proposed mechanism, as is, the formation of HTn from (-)-erythro-2-fluorocitrate. The structure of, the inhibited complex reveals that HTn binds like the inhibitor, trans-aconitate while providing all the interactions of the natural, substrate, isocitrate. The structure exhibits four hydrogen bonds &lt; 2.7 A, in length involving HTn, H2O bound to the [4Fe-4S] cluster, Asp-165 and, His-167, as well as low temperature factors for these moieties, consistent, with the observed very tight binding of the inhibitor.
+
It has been known for many years that fluoroacetate and fluorocitrate when metabolized are highly toxic, and that at least one effect of fluorocitrate is to inactivate aconitase. In this paper we present evidence supporting the hypothesis that the (-)-erythro diastereomer of 2-fluorocitrate acts as a mechanism based inhibitor of aconitase by first being converted to fluoro-cis-aconitate, followed by addition of hydroxide and with loss of fluoride to form 4-hydroxy-trans-aconitate (HTn), which binds very tightly, but not covalently, to the enzyme. Formation of HTn by these reactions is in accord with the working model for the enzyme mechanism. That HTn is the product of fluorocitrate inhibition is supported by the crystal structure of the enzyme-inhibitor complex at 2.05-A resolution, release of fluoride stoichiometric with total enzyme when (-)-erythro-2-fluorocitrate is added, HPLC analysis of the product, slow displacement of HTn by 10(6)-fold excess of isocitrate, and previously published Mossbauer experiments. When (+)-erythro-2-fluorocitrate is added to aconitase, the release of fluoride is stoichiometric with total substrate added, and HPLC analysis of the products indicates the formation of oxalosuccinate, and its derivative alpha-ketoglutarate. This is consistent with the proposed mechanism, as is the formation of HTn from (-)-erythro-2-fluorocitrate. The structure of the inhibited complex reveals that HTn binds like the inhibitor trans-aconitate while providing all the interactions of the natural substrate, isocitrate. The structure exhibits four hydrogen bonds &lt; 2.7 A in length involving HTn, H2O bound to the [4Fe-4S] cluster, Asp-165 and His-167, as well as low temperature factors for these moieties, consistent with the observed very tight binding of the inhibitor.
==About this Structure==
==About this Structure==
-
1FGH is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with SF4 and ATH as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Aconitate_hydratase Aconitate hydratase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.2.1.3 4.2.1.3] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1FGH OCA].
+
1FGH is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with <scene name='pdbligand=SF4:'>SF4</scene> and <scene name='pdbligand=ATH:'>ATH</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Aconitate_hydratase Aconitate hydratase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.2.1.3 4.2.1.3] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1FGH OCA].
==Reference==
==Reference==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Beinert, H.]]
[[Category: Beinert, H.]]
-
[[Category: Emptage, M.H.]]
+
[[Category: Emptage, M H.]]
-
[[Category: Kennedy, M.C.]]
+
[[Category: Kennedy, M C.]]
[[Category: Lauble, H.]]
[[Category: Lauble, H.]]
-
[[Category: Stout, C.D.]]
+
[[Category: Stout, C D.]]
[[Category: ATH]]
[[Category: ATH]]
[[Category: SF4]]
[[Category: SF4]]
Line 24: Line 24:
[[Category: lyase]]
[[Category: lyase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 14:54:20 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:38:26 2008''

Revision as of 10:38, 21 February 2008


1fgh, resolution 2.05Å

Drag the structure with the mouse to rotate

COMPLEX WITH 4-HYDROXY-TRANS-ACONITATE

Overview

It has been known for many years that fluoroacetate and fluorocitrate when metabolized are highly toxic, and that at least one effect of fluorocitrate is to inactivate aconitase. In this paper we present evidence supporting the hypothesis that the (-)-erythro diastereomer of 2-fluorocitrate acts as a mechanism based inhibitor of aconitase by first being converted to fluoro-cis-aconitate, followed by addition of hydroxide and with loss of fluoride to form 4-hydroxy-trans-aconitate (HTn), which binds very tightly, but not covalently, to the enzyme. Formation of HTn by these reactions is in accord with the working model for the enzyme mechanism. That HTn is the product of fluorocitrate inhibition is supported by the crystal structure of the enzyme-inhibitor complex at 2.05-A resolution, release of fluoride stoichiometric with total enzyme when (-)-erythro-2-fluorocitrate is added, HPLC analysis of the product, slow displacement of HTn by 10(6)-fold excess of isocitrate, and previously published Mossbauer experiments. When (+)-erythro-2-fluorocitrate is added to aconitase, the release of fluoride is stoichiometric with total substrate added, and HPLC analysis of the products indicates the formation of oxalosuccinate, and its derivative alpha-ketoglutarate. This is consistent with the proposed mechanism, as is the formation of HTn from (-)-erythro-2-fluorocitrate. The structure of the inhibited complex reveals that HTn binds like the inhibitor trans-aconitate while providing all the interactions of the natural substrate, isocitrate. The structure exhibits four hydrogen bonds < 2.7 A in length involving HTn, H2O bound to the [4Fe-4S] cluster, Asp-165 and His-167, as well as low temperature factors for these moieties, consistent with the observed very tight binding of the inhibitor.

About this Structure

1FGH is a Single protein structure of sequence from Bos taurus with and as ligands. Active as Aconitate hydratase, with EC number 4.2.1.3 Full crystallographic information is available from OCA.

Reference

The reaction of fluorocitrate with aconitase and the crystal structure of the enzyme-inhibitor complex., Lauble H, Kennedy MC, Emptage MH, Beinert H, Stout CD, Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13699-703. PMID:8942997

Page seeded by OCA on Thu Feb 21 12:38:26 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools